Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Porphyria in Sweden.

S Thunell1, Y Floderus, A Henrichson

  • 1Porphyria Centre Sweden, CMMS C2 71, Karolinska University Hospital Huddinge, Stockholm, Sweden. stig.thunell@karolinska.se

Physiological Research
|February 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric Day Case Tonsillectomy - Audit of a New Programme.

Irish medical journal·2020
Same author

What is the incidence of late detection of developmental dysplasia of the hip in England?: a 26-year national study of children diagnosed after the age of one.

The bone & joint journal·2019
Same author

The impact of morphine treatment on bladder cancer cell proliferation and apoptosis: in vitro studies.

Experimental oncology·2018
Same author

EPODE - A Model for Reducing the Incidence of Obesity and Weight-related Comorbidities.

European endocrinology·2018
Same author

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.

Journal of internal medicine·2018
Same author

Noise and transmission performance improvement of broadband distributed Raman amplifier using bidirectional Raman pumping with dual order co-pumps.

Optics express·2017
Same journal

Effects of THC, CBD, and Their Combination on EEG Dynamics in Rats.

Physiological research·2026
Same journal

Prophylactic Effect of Echinacoside on PIPN by Inhibiting Spinal Neuroinflammation and Exerting Neuroprotective Effects.

Physiological research·2026
Same journal

Comparison of Motor Learning Abilities Using Balance Training in Young and Senior Women.

Physiological research·2026
Same journal

The Role of NAT10-Mediated ac4C Modification in Osteoblast Function and Bone Formation: Insights from Integrative Bioinformatics and Experimental Validation.

Physiological research·2026
Same journal

Challenges and Solutions in Low-Biomass Respiratory Microbiome Profiling: A Workflow for Bronchoalveolar Lavage Fluid Sequencing in Guinea Pigs.

Physiological research·2026
Same journal

Sodium Selenite Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension by Upregulating GPX3 and Ameliorating Vascular Remodeling.

Physiological research·2026
See all related articles

Swedish porphyria research has advanced significantly, establishing a national center and registry for early diagnosis and improved patient care. This has drastically reduced mortality and morbidity from porphyria in Sweden.

Area of Science:

  • Biochemistry and Genetics
  • Medical History
  • Public Health

Background:

  • Porphyria research in Sweden traces back to Jakob Berzelius, evolving into modern molecular biology.
  • A national competence center and computerized registry for porphyria gene carriers have been established in Stockholm.

Purpose of the Study:

  • To present the historical development and current status of porphyria research and care in Sweden.
  • To detail the organization, services, and patient advocacy efforts related to porphyria in the country.
  • To highlight the impact of these initiatives on diagnosis, morbidity, and mortality.

Main Methods:

  • Historical review of Swedish porphyrinology.
  • Description of the national porphyria center, registry, and care network.

Related Experiment Videos

  • Analysis of porphyria prevalence, gene mutation spectra, and patient association activities.

    • Main Results:

    • Sweden has achieved early and accurate diagnosis for most porphyria gene carriers.
    • Porphyric morbidity has been significantly reduced through patient education and avoidance of triggers.
    • Mortality from acute porphyria phases is now rare, though hepatoma diagnoses have increased due to heightened awareness.

    Conclusions:

    • The combined efforts of the national porphyria center and patient association have dramatically improved porphyria management in Sweden.
    • Ongoing research focuses on gene therapy and enzyme replacement for acute intermittent porphyria.
    • Development of a drug porphyrinogenicity prediction model is crucial for evidence-based drug counseling.